Product Description: DTI 0009 is a selective adenosine A1 receptor agonist used to reduce heart rate in patients with atrial fibrillation and to treat arrhythmias[1].
Applications: Neuroscience-Neuromodulation
Formula: C17H24N6O4
References: [1]Venitz, J. et al. Dose-dependent pharmacokinetics (PK) of short IV infusions of selodenoson (DTI-0009), a novel adenosine (A1-) receptor agonist, in healthy subjects. Clinical Pharmacology & Therapeutics, 75(2), P28.
CAS Number: 110299-05-3
Molecular Weight: 376.41
Research Area: Neurological Disease
Solubility: 10 mM in DMSO
Target: Adenosine Receptor